The new neuromuscular blocker, Org NC 45 was applied to the toad sartorius nerve-muscle preparation. Measurement of the variance ratio of end-plate potentials recorded by micro-electrodes demonstrated that in concentrations greater than that required to block myoneural transmission, Org NC 45 reduced the quantal release of acetylcholine.
CrulJ.F., BooijLHDJ. First clinical experiences with Org Nc 45. Br J Anaesth1980; 52: 49S–52S.
2.
MarshallI.G., AgostonS., BooijLHDJ, DurantN.N., FoldesF.F.Pharmacology of Org NC 45 compared with other nondepolarizing neuromuscular blocking drugs. Br J Anaesth1980; 52: 11S–19S.
3.
MarshallR.J., McGrathJ.C., MillerR.D., DochertyJ.R., LamarJ.C.Comparison of the cardiovascular actions of Org NC 45 with those produced by other nondepolarizing neuro-muscular blocking agents in experimental animals. Br J Anaesth1980; 52: 21S–31S.
4.
AgostonS., SaltP., NewtonD., BenciniA., BoosmaP., ErdmanW.The neuromuscular blocking action of Org NC 45, a new pancuronium derivative, in anaesthetised patients. A pilot study. Br J Anaesth1980; 52: 53S–59S.
5.
DurantN.N., MarshallI.G., SavageD.S., NelsonD.N., SleighT., CarlyleI.C.The neuromuscular and autonomic blocking activities of pancuronium, Org NC 45 and other pancuronium analogues in the cat. J Pharm Pharmacol1979; 31: 831–836.
6.
Del CastilloJ., KatzB.Quantal components of the end-plate potential. J Physiol1954; 124: 560–573.
SinghY.N., HarveyA.L., MarshallI.G.Antibiotic-induced paralysis of the mouse phrenic nervehemidiaphragm preparation and reversibility by calcium and neostigmine. Anesthesiology1978; 48: 418–424.
9.
HubbardJ.I., WilsonD.F., MyamotoM.Reduction of transmitter release by d-tubocurarine. Nature1969; 223: 531–533.
10.
GalindoA.Prejunctional effect of curare: Its relative importance. J Neurophysiol1971; 34: 289–301.
